ID   ELOV7_HUMAN             Reviewed;         281 AA.
AC   A1L3X0; Q589T3; Q9H5D0; Q9NT66;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   15-MAR-2017, entry version 91.
DE   RecName: Full=Elongation of very long chain fatty acids protein 7 {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000305};
DE            EC=2.3.1.199 {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:21959040};
DE   AltName: Full=3-keto acyl-CoA synthase ELOVL7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=ELOVL fatty acid elongase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE            Short=ELOVL FA elongase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=Very long chain 3-ketoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
DE   AltName: Full=Very long chain 3-oxoacyl-CoA synthase 7 {ECO:0000255|HAMAP-Rule:MF_03207};
GN   Name=ELOVL7 {ECO:0000255|HAMAP-Rule:MF_03207};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Prostate;
RA   Tamura K., Nakagawa H., Nakamura Y.;
RT   "Overexpressed gene in prostate cancer.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 12-281.
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 124-281.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   FUNCTION.
RX   PubMed=19826053; DOI=10.1158/0008-5472.CAN-09-0775;
RA   Tamura K., Makino A., Hullin-Matsuda F., Kobayashi T., Furihata M.,
RA   Chung S., Ashida S., Miki T., Fujioka T., Shuin T., Nakamura Y.,
RA   Nakagawa H.;
RT   "Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth
RT   through saturated long-chain fatty acid metabolism.";
RL   Cancer Res. 69:8133-8140(2009).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=20937905; DOI=10.1073/pnas.1005572107;
RA   Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y.,
RA   Sassa T., Kihara A.;
RT   "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid
RT   synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18439-18444(2010).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND MUTAGENESIS OF HIS-150 AND HIS-151.
RX   PubMed=21959040; DOI=10.1016/j.febslet.2011.09.024;
RA   Naganuma T., Sato Y., Sassa T., Ohno Y., Kihara A.;
RT   "Biochemical characterization of the very long-chain fatty acid
RT   elongase ELOVL7.";
RL   FEBS Lett. 585:3337-3341(2011).
CC   -!- FUNCTION: Catalyzes the first and rate-limiting reaction of the
CC       four that constitute the long-chain fatty acids elongation cycle.
CC       This endoplasmic reticulum-bound enzymatic process, allows the
CC       addition of 2 carbons to the chain of long- and very long-chain
CC       fatty acids/VLCFAs per cycle. Condensing enzyme with higher
CC       activity toward C18 acyl-CoAs, especially C18:3(n-3) acyl-CoAs and
CC       C18:3(n-6)-CoAs. Also active toward C20:4-, C18:0-, C18:1-, C18:2-
CC       and C16:0-CoAs, and weakly toward C20:0-CoA. Little or no activity
CC       toward C22:0-, C24:0-, or C26:0-CoAs. May participate in the
CC       production of saturated and polyunsaturated VLCFAs of different
CC       chain lengths that are involved in multiple biological processes
CC       as precursors of membrane lipids and lipid mediators.
CC       {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:19826053,
CC       ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:21959040}.
CC   -!- CATALYTIC ACTIVITY: A very-long-chain acyl-CoA + malonyl-CoA = CoA
CC       + a very-long-chain 3-oxoacyl-CoA + CO(2). {ECO:0000255|HAMAP-
CC       Rule:MF_03207, ECO:0000269|PubMed:20937905,
CC       ECO:0000269|PubMed:21959040}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.6 uM for C18:3(n-3)-CoA {ECO:0000269|PubMed:21959040};
CC         KM=11.7 uM for malonyl-CoA {ECO:0000269|PubMed:21959040};
CC         Vmax=0.33 pmol/min/ug enzyme toward C18:3(n-3)-CoA
CC         {ECO:0000269|PubMed:21959040};
CC         Vmax=0.31 pmol/min/ug enzyme toward malonyl-CoA
CC         {ECO:0000269|PubMed:21959040};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:20937905,
CC       ECO:0000269|PubMed:21959040}.
CC   -!- INTERACTION:
CC       Q96EV8:DTNBP1; NbExp=3; IntAct=EBI-10285373, EBI-465804;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:20937905};
CC       Multi-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03207}.
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues except heart and
CC       skeletal muscle. {ECO:0000269|PubMed:20937905}.
CC   -!- DOMAIN: The C-terminal di-lysine motif may confer endoplasmic
CC       reticulum localization. {ECO:0000255|HAMAP-Rule:MF_03207}.
CC   -!- SIMILARITY: Belongs to the ELO family. ELOVL7 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03207}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15697.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15697.1; Type=Erroneous termination; Positions=52; Note=Translated as Gly.; Evidence={ECO:0000305};
CC       Sequence=BAB15697.1; Type=Frameshift; Positions=138; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB181393; BAD93238.1; -; mRNA.
DR   EMBL; BC130310; AAI30311.1; -; mRNA.
DR   EMBL; BC130312; AAI30313.1; -; mRNA.
DR   EMBL; AK027216; BAB15697.1; ALT_SEQ; mRNA.
DR   EMBL; AL137506; CAB70777.1; -; mRNA.
DR   CCDS; CCDS34164.1; -.
DR   PIR; T46257; T46257.
DR   RefSeq; NP_001098028.1; NM_001104558.1.
DR   RefSeq; NP_001284546.1; NM_001297617.1.
DR   RefSeq; NP_001284547.1; NM_001297618.1.
DR   RefSeq; NP_079206.2; NM_024930.2.
DR   RefSeq; XP_005248663.1; XM_005248606.4.
DR   RefSeq; XP_006714758.1; XM_006714695.3.
DR   RefSeq; XP_011541953.1; XM_011543651.2.
DR   RefSeq; XP_016865374.1; XM_017009885.1.
DR   UniGene; Hs.274256; -.
DR   ProteinModelPortal; A1L3X0; -.
DR   BioGrid; 123056; 3.
DR   IntAct; A1L3X0; 1.
DR   STRING; 9606.ENSP00000402634; -.
DR   SwissLipids; SLP:000000250; -.
DR   iPTMnet; A1L3X0; -.
DR   PhosphoSitePlus; A1L3X0; -.
DR   BioMuta; ELOVL7; -.
DR   EPD; A1L3X0; -.
DR   MaxQB; A1L3X0; -.
DR   PaxDb; A1L3X0; -.
DR   PRIDE; A1L3X0; -.
DR   DNASU; 79993; -.
DR   Ensembl; ENST00000425382; ENSP00000402634; ENSG00000164181.
DR   Ensembl; ENST00000508821; ENSP00000424123; ENSG00000164181.
DR   GeneID; 79993; -.
DR   KEGG; hsa:79993; -.
DR   UCSC; uc003jsi.5; human.
DR   CTD; 79993; -.
DR   DisGeNET; 79993; -.
DR   GeneCards; ELOVL7; -.
DR   H-InvDB; HIX0004886; -.
DR   HGNC; HGNC:26292; ELOVL7.
DR   HPA; HPA036337; -.
DR   MIM; 614451; gene.
DR   neXtProt; NX_A1L3X0; -.
DR   OpenTargets; ENSG00000164181; -.
DR   PharmGKB; PA134934034; -.
DR   eggNOG; KOG3071; Eukaryota.
DR   eggNOG; ENOG410XRWT; LUCA.
DR   GeneTree; ENSGT00760000119122; -.
DR   HOGENOM; HOG000038120; -.
DR   HOVERGEN; HBG051468; -.
DR   InParanoid; A1L3X0; -.
DR   KO; K10250; -.
DR   OMA; SQFFFME; -.
DR   OrthoDB; EOG091G0N2V; -.
DR   PhylomeDB; A1L3X0; -.
DR   TreeFam; TF323454; -.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00094; -.
DR   ChiTaRS; ELOVL7; human.
DR   GenomeRNAi; 79993; -.
DR   PRO; PR:A1L3X0; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164181; -.
DR   CleanEx; HS_ELOVL7; -.
DR   ExpressionAtlas; A1L3X0; baseline and differential.
DR   Genevisible; A1L3X0; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0102336; F:3-oxo-arachidoyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102337; F:3-oxo-cerotoyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102338; F:3-oxo-lignoceronyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009922; F:fatty acid elongase activity; EXP:Reactome.
DR   GO; GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB.
DR   HAMAP; MF_03207; VLCF_elongase_7; 1.
DR   InterPro; IPR030457; ELO_CS.
DR   InterPro; IPR002076; ELO_fam.
DR   InterPro; IPR033670; ELOVL7.
DR   PANTHER; PTHR11157; PTHR11157; 1.
DR   Pfam; PF01151; ELO; 1.
DR   PROSITE; PS01188; ELO; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    281       Elongation of very long chain fatty acids
FT                                protein 7.
FT                                /FTId=PRO_0000311988.
FT   TRANSMEM     28     48       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   TRANSMEM     73     93       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   TRANSMEM    116    136       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   TRANSMEM    143    162       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   TRANSMEM    172    194       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   TRANSMEM    207    227       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   TRANSMEM    237    257       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   MOTIF       277    281       Di-lysine motif. {ECO:0000255|HAMAP-
FT                                Rule:MF_03207}.
FT   MUTAGEN     150    150       H->A: Loss of activity; when associated
FT                                with A-151.
FT                                {ECO:0000269|PubMed:21959040}.
FT   MUTAGEN     151    151       H->A: Loss of activity; when associated
FT                                with A-150.
FT                                {ECO:0000269|PubMed:21959040}.
FT   CONFLICT     16     16       N -> K (in Ref. 3; BAB15697).
FT                                {ECO:0000305}.
FT   CONFLICT     37     37       Q -> H (in Ref. 3; BAB15697).
FT                                {ECO:0000305}.
FT   CONFLICT     80     80       V -> E (in Ref. 3; BAB15697).
FT                                {ECO:0000305}.
FT   CONFLICT    123    123       S -> C (in Ref. 3; BAB15697).
FT                                {ECO:0000305}.
FT   CONFLICT    250    250       L -> P (in Ref. 1; BAD93238).
FT                                {ECO:0000305}.
SQ   SEQUENCE   281 AA;  33356 MW;  33C3DA79704F6E9F CRC64;
     MAFSDLTSRT VHLYDNWIKD ADPRVEDWLL MSSPLPQTIL LGFYVYFVTS LGPKLMENRK
     PFELKKAMIT YNFFIVLFSV YMCYEFVMSG WGIGYSFRCD IVDYSRSPTA LRMARTCWLY
     YFSKFIELLD TIFFVLRKKN SQVTFLHVFH HTIMPWTWWF GVKFAAGGLG TFHALLNTAV
     HVVMYSYYGL SALGPAYQKY LWWKKYLTSL QLVQFVIVAI HISQFFFMED CKYQFPVFAC
     IIMSYSFMFL LLFLHFWYRA YTKGQRLPKT VKNGTCKNKD N
//
